Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2022 | 12-2021 | 09-2021 | 06-2021 | 12-2020 | |
| Sales | 2,939,791 | 0 | 0 | 2,967,901 | 0 |
| Cost of Goods | 684,299 | N/A | N/A | 566,302 | N/A |
| Gross Profit | 2,255,484 | N/A | N/A | 2,401,599 | N/A |
| Operating Expenses | 2,000,551 | 0 | 0 | 2,073,491 | 0 |
| Operating Income | 255,232 | N/A | N/A | 328,419 | N/A |
| Interest Expense | 18,449 | 0 | 0 | 15,625 | 0 |
| Other Income | 7,146 | 0 | 0 | 13,259 | 0 |
| Pre-tax Income | 243,928 | 0 | 0 | 326,053 | 0 |
| Income Tax | 52,876 | N/A | N/A | 46,810 | N/A |
| Net Income Continuous | 191,052 | N/A | N/A | 279,243 | N/A |
| Net Income | $191,052 | $N/A | $N/A | $279,252 | $N/A |
| EPS Basic Total Ops | 0.10 | N/A | N/A | 0.15 | N/A |
| EPS Basic Continuous Ops | 0.10 | N/A | N/A | 0.15 | N/A |
| EPS Diluted Total Ops | 0.10 | N/A | N/A | 0.15 | N/A |
| EPS Diluted Continuous Ops | 0.10 | N/A | N/A | 0.15 | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | 0.34 | 0.20 | N/A | 0.31 |
| EBITDA(a) | $539,154 | $N/A | $N/A | $493,520 | $N/A |